title: CA 50 serum levels in patients with liver diseases.
authors.affiliation: Tumor Markers Unit, Nuclear Medicine Service C.S., Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Genolla
authors.forename: G
authors.initials: G
authors.lastname: Moragas
authors.forename: S
authors.initials: S
authors.lastname: Mañe
authors.forename: M
authors.initials: M
authors.lastname: Rosell
authors.forename: A
authors.initials: A
authors.lastname: Cuartero
authors.forename: G
authors.initials: G
authors.lastname: Encabo
authors.forename: A
authors.initials: A
authors.lastname: Ruibal
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D006528:Carcinoma, Hepatocellular / Q000097:blood*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008113:Liver Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate